200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 63675-72-9

63675-72-9

63675-72-9 | Nisoldipine

CAS No: 63675-72-9 Catalog No: AG003T4E MDL No:MFCD00478055

Product Description

Catalog Number:
AG003T4E
Chemical Name:
Nisoldipine
CAS Number:
63675-72-9
Molecular Formula:
C20H24N2O6
Molecular Weight:
388.4144
MDL Number:
MFCD00478055
IUPAC Name:
3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
InChI:
InChI=1S/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3
InChI Key:
VKQFCGNPDRICFG-UHFFFAOYSA-N
SMILES:
COC(=O)C1=C(C)NC(=C(C1c1ccccc1[N+](=O)[O-])C(=O)OCC(C)C)C
EC Number:
264-407-7
NSC Number:
759106

Properties

Complexity:
704  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
388.163g/mol
Formal Charge:
0
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
388.42g/mol
Monoisotopic Mass:
388.163g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
110A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
3.3  

Literature

Title Journal
Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor. Scientific reports 20140101
FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1. Chemico-biological interactions 20130905
Role of action potential configuration and the contribution of C²⁺a and K⁺ currents to isoprenaline-induced changes in canine ventricular cells. British journal of pharmacology 20121001
Anti-arrhythmic and hemodynamic effects of oxy nifedipine, oxy nimodipine, oxy nitrendipine and oxy nisoldipine. Pharmacological research 20121001
Tetrodotoxin blocks L-type Ca2+ channels in canine ventricular cardiomyocytes. Pflugers Archiv : European journal of physiology 20120801
The inhibitory effects of m-nisoldipine on the 5-hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells via Ca2+ antagonism and antioxidant mechanisms. European journal of pharmacology 20120705
Effect of nisoldipine and olmesartan on endothelium-dependent vasodilation in essential hypertensive patients. CNS neuroscience & therapeutics 20120501
Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism. Bioorganic & medicinal chemistry letters 20120115
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Identification of clinically used drugs that activate pregnane X receptors. Drug metabolism and disposition: the biological fate of chemicals 20110101
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals 20101201
Simultaneous determination of m-nisoldipine and its three metabolites in rat plasma by liquid chromatography-mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101101
Preparation of a novel glycidyl methacrylate-based monolith and its application for the determination of m-nisoldipine in human plasma. Journal of chromatographic science 20100701
The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nature reviews. Nephrology 20100601
Characterization of the rapidly activating delayed rectifier potassium current, I (Kr), in HL-1 mouse atrial myocytes. The Journal of membrane biology 20100601
[Effect of m-nisoldipine on the Ca2+/CaM/CaN signal pathway in 5-HT-induced proliferation of rat PASMCs]. Yao xue xue bao = Acta pharmaceutica Sinica 20100101
Capillary electrophoretic enantioseparation of m-nisoldipine using two different beta-cyclodextrins. Journal of separation science 20090901
Calcium channel blocker-associated small bowel angioedema. Journal of clinical gastroenterology 20090401
Serum phosphorus and cardiovascular mortality in type 2 diabetes. The American journal of medicine 20090401
Tissues distribution of R-(-)- and S-(+)-m-nisoldipine after single enantiomer administration in rats. Drug development and industrial pharmacy 20090101
Effects of three metabolites of propiverine on voltage-dependent L-type calcium currents in human atrial myocytes. European journal of pharmacology 20081119
Gingival hyperplasia in a patient with hypertension. Journal of clinical hypertension (Greenwich, Conn.) 20081101
m-Nisoldipine attenuates monocrotaline-induced pulmonary hypertension by suppressing 5-HT/ERK MAPK pathway. Yao xue xue bao = Acta pharmaceutica Sinica 20081001
T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers. Life sciences 20080312
Nisoldipine exposures. The American journal of emergency medicine 20080301
Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects. Heart and vessels 20071101
Telmisartan improves endothelial function in patients with essential hypertension. Journal of cardiovascular pharmacology 20071001
Adenoviral-mediated expression of dihydropyridine-insensitive L-type calcium channels in cardiac ventricular myocytes and fibroblasts. European journal of pharmacology 20070622
Pharmacologic agents in the management of hypertension--nisoldipine coat-core. Journal of clinical hypertension (Greenwich, Conn.) 20070401
Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension. Stem cells and development 20070401
Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertension. Journal of clinical pharmacology 20070301
Simple and sensitive determination of nisoldipine in plasma using liquid chromatography-tandem mass spectrometry. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20061201
Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension. Metabolism: clinical and experimental 20060901
Validated LC-MS-MS method for determination of m-nisoldipine polymorphs in rat plasma and its application to pharmacokinetic studies. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060501
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
An overview on the homeostasis of Ca2+ in chemoreceptor cells of the rabbit and rat carotid bodies. Advances in experimental medicine and biology 20060101
Thermal stability of 1,4-dihydropyridine derivatives in solid state. Acta poloniae pharmaceutica 20060101
Photoprotection of 1,4-dihydropyridine derivatives by dyes. International journal of pharmaceutics 20051104
Subtype switching of L-Type Ca 2+ channel from Cav1.3 to Cav1.2 in embryonic murine ventricle. Circulation journal : official journal of the Japanese Circulation Society 20051101
Evaluation of titanium dioxide as a pharmaceutical excipient for preformulation of a photo-labile drug: effect of physicochemical properties on the photostability of solid-state nisoldipine. Chemical & pharmaceutical bulletin 20050701
Effect of L-type calcium channel antagonists on spermine-induced CNS excitation in vivo. Neuroscience letters 20050603
Prediction of genotoxicity of chemical compounds by statistical learning methods. Chemical research in toxicology 20050601
The effect of beta-carotene on the photostability of nisoldipine. Methods and findings in experimental and clinical pharmacology 20050401
Mobilization of sarcoplasmic reticulum stores by hypoxia leads to consequent activation of capacitative Ca2+ entry in isolated canine pulmonary arterial smooth muscle cells. The Journal of physiology 20050301
Role of nitric oxide in Ca2+ sensitivity of the slowly activating delayed rectifier K+ current in cardiac myocytes. Circulation research 20050107
Effects of a mononitrate, a beta1-blocker and a dihydropyridine calcium channel blocker on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study in normotensive volunteers. Arzneimittel-Forschung 20050101
[Toxicological analysis of selected 1,4-dihydropyridine calcium channel blockers in the diagnosis of intoxications]. Archiwum medycyny sadowej i kryminologii 20050101
Effects of nanomolar concentration dihydroouabain on calcium current and intracellular calcium in guinea pig ventricular myocytes. Life sciences 20041224
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 20041001
High-performance liquid chromatography-electrospray ionization mass spectrometric determination of nisoldipine in human plasma. Journal of chromatographic science 20041001
Cholecystokinin octapeptide increases free intracellular calcium of guinea pig cardiomyocytes through activation of Ca2+ channel and tyrosine kinase. Sheng li xue bao : [Acta physiologica Sinica] 20040225
Block of cardiac delayed-rectifier and inward-rectifier K+ currents by nisoldipine. British journal of pharmacology 20031101
Enhanced expression of L-type Cav1.3 calcium channels in murine embryonic hearts from Cav1.2-deficient mice. The Journal of biological chemistry 20031017
Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension. American journal of hypertension 20030901
Photochemical degradation of solid-state nisoldipine monitored by HPLC. Journal of pharmaceutical and biomedical analysis 20030808
Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study. Heart (British Cardiac Society) 20030801
Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial. American heart journal 20030601
Endocardial versus epicardial differences in L-type calcium current in canine ventricular myocytes studied by action potential voltage clamp. Cardiovascular research 20030401
An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty. American heart journal 20030301
Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 20030211
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris. The American journal of cardiology 20030201
Reactivity of 1,4-dihydropyridines toward alkyl, alkylperoxyl radicals, and ABTS radical cation. Chemical research in toxicology 20030201
Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus. European journal of clinical pharmacology 20021201
Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. The Journal of biological chemistry 20021122
Increased cyclosporine blood levels after nisoldipine administration in a renal transplant recipient. Transplant international : official journal of the European Society for Organ Transplantation 20021101
Evidence that action potential generation is not the exclusive determinant to trigger spontaneous myogenic contraction of guinea-pig urinary bladder smooth muscle. Acta physiologica Scandinavica 20020901
Developmental changes of Ca(2+) handling in mouse ventricular cells from early embryo to adulthood. Life sciences 20020802
Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20020801
L-type Ca2+ channels of the embryonic mouse heart. European journal of pharmacology 20020705
Hydrolytic degradation of nitrendipine and nisoldipine. Journal of pharmaceutical and biomedical analysis 20020601
[Effect of grapefruit pulp on the pharmacokinetics of the dihydropyridine calcium antagonists nifedipine and nisoldipine]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20020501
Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis. Cardiovascular research 20020501
[Blood pressure amplitude in the morning must be reduced. Saving the hypertensive patient from infarct]. MMW Fortschritte der Medizin 20020307
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney international 20020301
Interaction of digoxin with antihypertensive drugs via MDR1. Life sciences 20020215
Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide. Pharmacological research 20020101
Membrane depolarization, elevated Ca(2+) entry, and gene expression in cerebral arteries of hypertensive rats. American journal of physiology. Heart and circulatory physiology 20011201
Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders. Journal of oral science 20011201
Cardiac remodeling after long term norepinephrine treatment in rats. Cardiovascular research 20011101
Effects of different types of K+ channel modulators on the spontaneous myogenic contraction of guinea-pig urinary bladder smooth muscle. Acta physiologica Scandinavica 20011101
Enantioselective assay of nisoldipine in human plasma by chiral high-performance liquid chromatography combined with gas chromatographic-mass spectrometry: applications to pharmacokinetics. Journal of chromatography. B, Biomedical sciences and applications 20011005
Decrease in the Ca2+-activated K+ current of pulmonary arterial smooth muscle in pulmonary hypertension rats. Naunyn-Schmiedeberg's archives of pharmacology 20010901
Selectivity of blocking of low- versus high-voltage activated calcium currents by the dihydropyridine derivatives Bay E5759 and Bay A4339 in neuroblastoma--glioma NG 108-15 cells. Pharmacological research 20010801
Nisoldipine increases the bioavailability of endothelial NO. Naunyn-Schmiedeberg's archives of pharmacology 20010801
Comparison of 24-hour blood pressure profiles in patients with hypertension who were switched from amlodipine to nisoldipine. Pharmacotherapy 20010801
Mechanisms of coronary artery depolarization by uridine triphosphate. American journal of physiology. Heart and circulatory physiology 20010601
Control of secretion by mitochondria depends on the size of the local [Ca2+] after chromaffin cell stimulation. The European journal of neuroscience 20010601
The slow component of the delayed rectifier potassium current in undiseased human ventricular myocytes. Cardiovascular research 20010301
Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven. The American journal of cardiology 20010101
A prospective comparison of four antihypertensive agents in daily clinical practice. Journal of clinical hypertension (Greenwich, Conn.) 20010101
Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. The Journal of biological chemistry 20001215
Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen. Journal of molecular and cellular cardiology 20000201
Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions. European journal of clinical pharmacology 20000101
Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. American journal of hypertension 19990801
Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure. Heart disease (Hagerstown, Md.) 19990101
Nisoldipine selectively induces coronary vasodilation and improves mild myocardial ischemia in dogs: a potential role of cellular acidosis. Cardiovascular drugs and therapy 19981201
A comparison of nisoldipine coat-core and felodipine in the treatment of mild-to-moderate hypertension. International journal of clinical practice 19980601
Protective effect of nisoldipine on dipyridamole-induced myocardial ischemia: correlation with exercise electrocardiography. Coronary artery disease 19980101
New evidence on the prevention of cardiovascular events in hypertensive patients with type 2 diabetes. Journal of cardiovascular pharmacology 19980101
Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group. Cardiovascular drugs and therapy 19970901
Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease. Angiology 19970601
Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators. American journal of hypertension 19970301
Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction. American heart journal 19970301
Nisoldipine CC: clinical experience in hypertension. Cardiology 19970101
Plasma endothelin-1 concentrations in patients with coronary artery disease during stress test before and after nisoldipine administration. Acta cardiologica 19960101
Nisoldipine improves ventricular function in rats with ischemic heart failure. Journal of molecular and cellular cardiology 19950901
The effects of nisoldipine on carotid artery stiffness and left ventricular functions. Japanese heart journal 19950901
Acute effects of intravenous nisoldipine on left ventricular function after acute myocardial infarction. Cardiovascular drugs and therapy 19940501
Cardiovascular effects of nisoldipine in essential hypertension. Israel journal of medical sciences 19940201
A proischaemic action of nisoldipine: relationship to a decrease in perfusion pressure and comparison to dipyridamole. Cardiovascular research 19930701
The acute effects of intravenous nisoldipine on left ventricular function within 24 h after acute myocardial infarction. European heart journal 19921201
Improved diastolic function with the calcium antagonist nisoldipine (coat-core) in patients post myocardial infarction: results of the DEFIANT study. Doppler Flow and Echocardiography in Functional cardiac Insufficiency: Assessment of Nisoldipine Therapy. European heart journal 19921101
Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group. The American journal of cardiology 19911015
Effects of nisoldipine on stress-induced changes in haemodynamics and plasma catecholamines in normotensives and hypertensives. Journal of human hypertension 19901201
The initial hemodynamic response to newer antihypertensive agents at rest and during exercise: review of visacor, doxazosin, nisoldipine, tiapamil, perindoprilat, pinacidil, dilevalol, and carvedilol. Cardiovascular drugs and therapy 19900801
Hemodynamic mechanisms of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina. Circulation 19900601
[Responses of plasma eicosanoids and hemodynamics to myocardial ischemia and the salutary effect of calcium entry blocker]. Nihon Ika Daigaku zasshi 19900201
Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Drugs 19881201
The acute effects of intravenous nisoldipine on left ventricular function 24 to 72 hours after uncomplicated acute myocardial infarction. Cardiovascular drugs and therapy 19881201
Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications. Journal of clinical pharmacology 19871101
Effects of nisoldipine on left ventricular function during exercise or cold pressor stress. European heart journal 19871101
Monotherapy with the calcium channel antagonist nisoldipine for systemic hypertension and comparison with diuretic drugs. The American journal of cardiology 19870915
Arrhythmogenic action of alpha 1-adrenoceptor stimulation in normoxic rat ventricular myocardium: influence of nisoldipine, reduced extracellular Ca2+ and ryanodine. Journal of molecular and cellular cardiology 19870901
Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina. American heart journal 19870201
Renal effects of 1,4-dihydropyridines in animal models of hypertension and renal failure. Journal of cardiovascular pharmacology 19870101
The hypotensive effect of nisoldipine in renovascular hypertensive rats. Journal of hypertension. Supplement : official journal of the International Society of Hypertension 19861201
Alteration of left ventricular diastolic filling in hypertensive patients: effects of nitrendipine and atenolol. European heart journal 19860901

© 2019 Angene International Limited. All rights Reserved.